While our previous studies have found the elevated H3K4me3 in a familial AD model (5xFAD)17, it is unclear whether Smyd3-Fbxo2-NR1 pathway is also altered in 5xFAD mice. This evidence concerns the gene SMYD3 and Alzheimer disease.